← Browse by Condition
Medical Condition

other solid tumors

Total Trials
1
Recruiting Now
1
Trial Phases
EARLY_Phase 1
NCT06577532 EARLY_Phase 1
Recruiting

Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors

Enrollment
56 pts
Location
China
Sponsor
Ruijin Hospital
View Trial →